1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with aminocaproic acid in 2 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (aminocaproic acid) | Trials (aminocaproic acid) | Recent Studies (post-2010) (aminocaproic acid) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 1,793 | 132 | 302 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bulbena, O; Casanovas, LI; Escolar, G; Galmés, JL; Navarro, C | 1 |
Crooks, S; Knox, P; Patel, S; Scaife, MC | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and aminocaproic acid
Article | Year |
---|---|
Zinc acexamate reduces gastric damage induced by platelet-activating factor.
Topics: Aminocaproates; Aminocaproic Acid; Animals; Blood Pressure; Gastric Mucosa; Male; Mast Cells; Platelet Activating Factor; Rats; Rats, Inbred Strains; Stomach; Stomach Ulcer | 1989 |
Role of plasminogen, plasmin, and plasminogen activators in the migration of fibroblasts into plasma clots.
Topics: Aminocaproic Acid; Blood Coagulation; Cell Count; Cell Movement; Dose-Response Relationship, Drug; Fibrinolysin; Fibrinolysis; Fibroblasts; Humans; Plasminogen; Platelet Activating Factor | 1987 |